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Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: systematic review Alcoholism is one of the most prevalent psy chiatric disorders. In 2001-2002, the 12month prevalence of alcohol dependence in the USA was 3.7% [1] . Heritability estimates for alcohol dependence are high and range from 50 to 70% in both men and women, as is shown by numer ous twin and adoption studies [2] [3] [4] [5] [6] . In attempts to discover the nature of this genetic liability for alcoholism, genes involved in dopaminergic circuits have received much attention. Alcohol is known to activate the dopaminergic system, which in turn is associated with positive rein forcement [7, 8] . Thus, genetic variation in the function or regulation of genes coding for pro teins involved in dopamine neurotransmission might account for different responses to alcohol or might contribute to individual variation in vulnerability to alcohol abuse [9] .
Essential in dopamine regulation is the dopa mine transporter (DAT). DAT belongs to the family of Na + /Cl dependent transmembrane transport proteins [10] , and is responsible for the reuptake of extracellular synaptic dopamine into presynaptic neurons, hereby terminating dopaminergic neurotransmission [11] . As such, dopaminergic reward circuits are likely to func tion differently when DAT expression levels differ [12] , which makes the gene encoding the transporter (SLC6A3/DAT1) an attractive can didate in clinical studies on alcohol dependence.
The mechanism by which DAT availabil ity is regulated in the brain is still not exactly understood. Neuroimaging studies show that DAT levels may be affected by chronic alco hol use. DAT levels were significantly lower in the striatum of alcoholdependent humans and monkeys than in controls, but returned to control levels after a period of abstinence [13, 14] . Also, striatal DAT density was markedly lower in nonviolent type 1 alcoholics than in control subjects [15, 16] . This difference was not signifi cant for violent, type 2 alcoholics. Two other studies did not find reductions in DAT levels in the brains of alcoholics when compared with controls [17, 18] , although this might be related to the fact that measurements were carried out up to several weeks after alcohol withdrawal, in which DAT levels may have already returned to normal.
Alternatively, DAT availability in the brain may be dependent on genetic variation. The DAT gene (DAT1; locus symbol SLC6A3) is localized on chromosome 5p15.3. Although many parts of the gene are highly conserved in evolutionary aspect [19] , several, mainly non functional variants have been identified in DAT1 in different populations (see e.g., [20] [21] [22] [23] [24] ). For example, a SNP in the 3´UTR of DAT1 consists of a G to A mutation at position 2319 in DAT cDNA (2319G>A) and has been described in several recent studies [22, 25, 26] . The genetic polymorphism of interest in most studies on alcohol dependence, however, is a variable num ber of tandem repeats (VNTR) of 40 bp. For the VNTR, numbers ranging from three to 16 have been described, with the 9 and 10repeat Dopamine neurotransmission has been a key player in attempts to identify genetic factors involved in alcohol dependence. The dopamine transporter terminates dopaminergic neurotransmission, making the gene encoding the transporter (SLC6A3/DAT1) an attractive candidate in clinical studies on alcohol dependence. We conducted a systematic review of 18 studies examining associations between polymorphisms in DAT1 and alcohol dependence. The DAT1 variable number tandem repeat, the most frequent studied polymorphism in DAT1, did not show a direct association with alcohol dependence in general. Several, but not all, studies found that the DAT1 variable number tandem repeat (9-repeat allele) was associated with alcohol-withdrawal symptoms, such as seizures and delirium tremens. We discuss shortcomings, such as lack of power and disregarding moderating variables, as well as future challenges of gene association studies.
KEYWORDS: alcohol dependence n alcoholism n DAT1 n dopamine transporter n polymorphism n review n SLC6A3 2 future science group Review van der Zwaluw, Engels, Buitelaar, Verkes, Franke & Scholte alleles being the most common variants [19, 24] . Several studies have demonstrated ethnic differ ences in DAT1 VNTR frequency distributions (e.g., [27] [28] [29] ). Since the VNTR is located in the 3´UTR of the gene, outside the open reading frame of the gene, allelic variants do not result in structural or functional differences in the DAT protein. Nonetheless, research suggests that the DAT1 VNTR is able to regulate specific gene functioning by influencing levels of expression. As such, DAT expression may be influenced by alteration in the length or sequence of the DAT1 VNTR (for more info on the effects of 3´UTRs on translation and transcription see [30] ). It is also likely that the VNTR is in linkage disequi librium with other susceptibility loci within the gene. Greenwood et al. discovered a high degree of linkage disequilibrium between SNPs in the 5´ and 3´ regions of DAT1 [31] . In addition, the VNTR polymorphism was in significant linkage disequilibrium (D´ > 0.50) with at least six SNPs within DAT1.
From the literature, it is not exactly clear whether high or low levels of DAT are likely to predispose to alcoholism. In the animal litera ture, one rodent study has shown that female DAT knockout mice showed decreased alco hol intake [32] , indicating that low or abstinent levels of DAT result in higher levels of extra cellular dopamine and subsequently in less alcohol intake. In contrast, Hall et al. found that male DAT knockout mice increased their alcohol intake and that female heterozygous mice showed increased alcohol preference [33] . In the human literature, both the 9 and the 10repeat allele have been repeatedly associated with increased DAT expression [34] [35] [36] [37] [38] [39] [40] , and as such both may be treated as risk alleles.
In the current study we give a thorough review of the clinical studies that examined the asso ciation between DAT1 and alcohol dependence either in a case-control or in a familybased design.
Method of search
A literature search was carried out using Ovid Medline and PubMed. Keywords used were 'dopamine transporter', 'DAT1', 'DAT', com bined with 'alcohol', 'dependence', and 'alco holism'. Studies were included if they examined the DAT1 VNTR polymorphism or the DAT1 2319G>A polymorphism, and if they applied a case-control, case only or a familybased design. Studies that were carried out on postmortem cases (e.g., [41] ) were left out of the review. A total of 18 studies were included in the present review. We first give a short, general summary of the findings of the studies. Subsequently the reviewed studies are described individu ally, and then in more detail, in a chronological order (Table 1 & 2) . The 15 studies examining the DAT1 VNTR polymorphism are described sepa rately from the three studies that examined the DAT1 2319G>A polymorphism, which are not included in the general summary below.
General summary
In a general case-control design, the vast major ity of studies did not find significant differences in DAT1 VNTR frequency between alcohol dependent subjects and controls [23, 35, [42] [43] [44] [45] [46] [47] [48] [49] . Only Köhnke et al. found that the 9repeat allele was significantly more frequent in German alcoholics than in controls [50] . When applying a familybased design, two studies did not show a significant transmission of one of the DAT1 VNTR alleles to alcohol dependent offspring [45, 51] , while one did find a significant transmis sion of the 10repeat allele [47] .
Since alcoholdependent subjects are not nec essarily a homogeneous group, several researchers created subgroups, often based on the presence or absence of certain alcoholwithdrawal symp toms [42, 43, 46, [50] [51] [52] [53] [54] . Several studies showed that the 9repeat allele was more often present in a subgroup of alcoholics with a variety of alcohol withdrawal symptoms, such as withdrawal sei zures and delirium tremens [43, 46, 52] , paroxysmal sweats and tremors [54] , and visual hallucinations [53] when compared with controls. Others did not find the 9repeat allele to be associated with alcoholwithdrawal symptoms [50, 51] . For a more detailed overview of the studies please see below and Table 1 and 2. n Clinical studies on the DAT1 VNTR & alcohol dependence
Muramatsu and Higuchi were the first to test for differences in DAT1 VNTR allele prevalence between alcoholdependent and control subjects [44] . In their Japanese sample, they differenti ated between 80 alcoholics with the aldehyde dehydrogenase2 (ALDH2) polymorphism, 132 alcoholics without this variant and 235 controls. Individuals with the ALDH2*2 variant display decreased ALDH2 enzyme activity, which reduces efficient breakdown of alcohol con sumed [55] . This in turn creates the wellknown flushing response and disproportional headaches and nausea after limited alcohol consumption. Since alcoholic persons with the ALDH2*2 allele had overcome their original genetic protection Review van der Zwaluw, Engels, Buitelaar, Verkes, Franke & Scholte against alcoholism, the authors reasoned that they must share another susceptibility factor, possibly represented by a DAT1 polymorphism. No differences in DAT1 VNTR allele frequency were found between the alcoholics without the ALDH2*2 allele and controls. However, the 7repeat allele occurred significantly more often in alcoholic persons with the ALDH2*2 allele than in controls (p < 0.05). No significant dif ferences were found in the frequencies of the 9repeat or 10repeat alleles between alcohol ics with the ALDH2*2 allele and controls. The authors concluded that as the search for suscep tibility genes with regard to alcohol dependence is complicated by the heterogeneity of the dis ease, focusing on specific subpopulations might be helpful. Thus, for Japanese persons with the ALDH2 inactivity allele, an additional variation in DAT1 may increase the risk for alcoholism. Sander et al. also formed subgroups of their sample of 293 Caucasian alcoholics [46] . They created clinically relevant subgroups based on positive family history, early age at onset, delir ium, withdrawal seizures, antisocial tendencies, and type 1 and type 2 alcoholism. When com pared with the 93 controls, alcoholics with an alcoholrelated delirium or with withdrawal sei zures showed significantly increased prevalence of the DAT1 VNTR 9repeat allele (odds ratio [OR]: 2.49; p = .01 and OR: 2.48; p = 0.01, respectively). In addition, alcoholics homozy gous for the 9repeat allele were significantly more prevalent in the antisocial subgroup, and in the subgroup of type 2 alcoholics (OR: 3.37; p = 0.04 and OR: 4.59; p = 0.01, respectively). The entire group of alcoholdependent individu als, or the other subgroups (positive family his tory, early age at onset and type 1 alcoholics) showed no difference in 9repeat allele frequency compared with controls. The authors suggested that the 9repeat allele might be mainly associ ated with more severe alcoholinduced neuro adaptive alterations in the brain and with the expression of somatic withdrawal symptoms. In accordance with Muramatsu and Higuchi [44] further emphasized that considering alcoholics as one homogeneous group might not be the best way to examine genotype-phenotype associa tions [44] .
Dobashi, Inada, and Hadano studied several dopaminerelated genes and polymorphisms, among which the DAT1 VNTR, in a Japanese sample of 80 alcoholics and 120 control sub jects [48] . Although the frequency of the 7repeat allele was higher in alcoholdependent patients than in controls, and the 9repeat allele was less frequent in alcoholics than in controls, these results were only borderline significant (p < 0.10). The authors mentioned that gene loci might be related to characteristics of per sonality or psychosis that predispose to addictive behavior, rather than to this behavior itself. They also pointed to the fact that ethnic differences between samples may produce different results. The DAT1 7repeat allele has, for example, only been detected in Japanese and Chinese populations [27] .
Parsian and Zhang did not find any evidence for a significant association between the DAT1 VNTR polymorphism and alcohol dependence in their Caucasian sample [45] . They compared DAT1 allele (9, 10, 11repeat allele) frequencies in 162 type 1 and type 2 alcoholics with those of 89 unrelated controls. No significant differences were found between the total group of alcohol ics and controls (p = 0.572), nor between type 1 and type 2 alcoholics (p = 0.347). To con trol for potential stratification effects caused by nonaccurate matching of cases' and control sub jects' ethnicity in the case-control design, the researchers also carried out a haplotype relative risk ana lysis. In this approach the frequency of transmitted haplotypes (case) is compared with the frequency of nontransmitted haplotypes (control) within a family, hereby controlling for stratification problems [56] . In 29 families, the alcoholic proband and both parents were geno typed. Haplotypes containing the 9repeat risk allele were not transmitted more often to alco holdependent probands than haplotypes with out this allele (p = 0.461). The authors concluded that the DAT1 VNTR polymorphism was not associated with alcoholism in their sample.
Schmidt and coworkers examined whether withdrawal symptoms in 48 chronically intoxi cated, German, male alcoholics differed with the presence or absence of the DAT1 9repeat allele [54] . The 22 patients with the 9repeat allele reported significantly higher levels of alco hol withdrawal symptoms, such as paroxysmal sweats and tremors, than patients homozygous for the 10repeat allele (p = 0.04). Stepwise mul tiple regression ana lysis showed that the amount of alcohol consumed in the preceding month was related to withdrawal symptoms (b = 0.42; p = 0.005), and that the DAT1 VNTR genotype showed a nearly significant trend towards asso ciation with withdrawal symptoms (b = 0.24; p = 0.10). The authors suggested that the DAT1 VNTR may play a role in the brain's capacity to adapt and compensate for longterm effects of alcohol use. Vandenbergh et al.
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A u t h o r P r o o f future science group
Review van der Zwaluw, Engels, Buitelaar, Verkes, Franke & Scholte [46] 2319-A allele not more frequent in cases than in controls (in total group nor in subgroups). A10 ¶ was more frequent in subgroups 2 (p = 0.02), 4 (p = 0.03) and 5 (p < 0.01) (see Samochowiec et al.
n.r. [45] , although the authors mentioned that the use of anti convulsive medication and consequently the severity of withdrawal symptoms, might have confounded the results.
Vandenbergh et al. sequenced the entire 60,000 bp of DAT1 in 150 control subjects, 109 individuals meeting criteria for Tourette's syndrome, 15 individuals with attention defi cit-hyperactivity disorder (ADHD), and in 64 individuals with alcohol dependence (all sub jects were of Caucasian descent) [23] . The authors discovered a SNP in exon 15, resulting in a base substitution of C into T, which, however, did not have a functional consequence with regard to a change in amino acid. A total of 12 other, rare variants in exon 2 and exon 8 resulted in a change in the amino acid sequence, while all other SNPs in DAT1 did not. Although both the VNTR 10repeat allele and the newly discov ered exon 15 SNP were significantly more often transferred to subjects with ADHD, no differ ence in allele frequencies between cases and con trols was found for alcoholism (0.16 < p < 0.93). Vandenbergh and colleagues stated that DAT may still be involved in alcohol dependence and other neuro psychiatric disorders, but perhaps in a more complex way, such as in genetic hetero genic processes or gene-environment interac tions [23] . Since the majority of the polymor phisms found in DAT1 did not result in amino acid changes, the authors also suggested that variations in levels of expression, induced by genetic variants in promoter/enhancer regions, rather than differences in protein sequences, may explain variability in individuals' genetic liabili ties for alcoholism.
In the study by Heinz et al. single photon emission computed tomography (SPECT) was used to measure differences in DAT availability in caudate and putamen brain areas of 14 absti nent alcoholics and 11 control subjects (ethnic ity was not reported) [35] . Although the 9repeat allele was more frequent in alcoholdependent subjects than in control subjects, the difference was not significant (pvalue was not reported). DAT availability in caudate and putamen did also not significantly differ between alcoholic and control subjects (p = 0.26 and p = 0.43 respectively). Genotype did affect DAT avail ability in putamen in the total sample (p < 0.05), with persons with the DAT1 9repeat allele exhibiting lower binding potential than inidivid uals homozygous for the 10repeat allele. No sig nificant effect of genotype on DAT availability was found for the caudate (p = 0.11). Regardless of the small sample size, the authors also tested for several confounding variables. No significant differences were found in age, negative symp toms (anhedonia, apathy, affective flattening), occupational status, educational level, impul sivity, anxiety and depression levels between persons carrying the 9repeat allele and those homozygous for the 10repeat allele. It was sug gested that the reduction in DAT availability in alcoholic subjects with the 9repeat allele, result ing in decreased clearance of synaptic dopamine, may make these individuals more sensitive to druginduced dopamine surges, especially dur ing alcoholwithdrawal periods.
Chen and coworkers studied a group of Han Chinese and four ethnically homogeneous groups from the Taiwanese population; Atayal, Ami, Bunun, and Paiwan [42] . The 203 alcoholic subjects all reported alcohol dependence with withdrawal symptoms. A subgroup of severe alcoholdependent subjects was created with participants who displayed impairment of liver function, peripheral neuropathy or hallucina tions. The 213 control subjects were matched with the alcoholic subjects based on ethnicity and age and were excluded when they smoked at least one pack of cigarettes per day. No sig nificant differences in DAT1 genotype distribu tions were found between the control and the alcoholic subjects, either for the total groups of alcoholics (Atayal: p = 1.00; Ami: p = 0. Review van der Zwaluw, Engels, Buitelaar, Verkes, Franke & Scholte Han: p = 0.77). The authors acknowledged that the relatively small sample sizes (65 < n < 158) of the different ethnic groups could have resulted in insufficient power to detect associations.
Bau and colleagues examined differences in DAT1 VNTR allele frequencies between 114 Brazilian cases and 112 Brazilian controls in a c 2 test [49] . No significant differences were found (p = 0.31). However, in a regression ana lysis the DAT1 10/10 genotype did significantly pre dict levels of alcohol consumption (p = 0.04). Additionally, an interaction effect between the noveltyseeking personality trait and the DAT1 10/10 genotype was found (p = 0.04). The authors suggested that carrying the DAT1 10/10 genotype may enhance alcoholseeking behavior in individuals who score high on nov elty seeking.
Gorwood et al. studied the role of the DAT1 VNTR in alcoholwithdrawal symptoms (alco holwithdrawal seizure and delirium tremens) by comparing 120 Caucasian male alcoholics with 65 control subjects [52] . Alcoholdependent patients with the 9repeat allele more frequently experienced at least one episode of alcohol withdrawal seizure or delirium tremens, and had more often taken alcohol to reduce with drawal symptoms than alcoholdependent patients without the 9repeat allele (p = 0.03 and p = 0.02, respectively). The average number of withdrawal symptoms was not significantly dif ferent between alcoholdependent patients with and those without the 9repeat allele (p = 0.33). The 9repeat allele occurred more frequently in patients with antisocial personality disor der than in the rest of the alcoholdependent sample (p = 0.03), and excluding these patients enhanced the association between the 9repeat allele and alcoholism with alcohol withdrawal seizures and delirium tremens (p = 0.02). The 9repeat allele was also significantly more often observed in older patients (p < 0.01) and in patients with a longer history of alcohol depend ence (p < 0.01). Additionally, a principal com ponent ana lysis showed that delirium tremens and alcoholwithdrawal seizures together formed one component of alcoholwithdrawal symptoms in the patient sample, suggesting that patients with seizures and delirium tremens may repre sent a rather homogeneous group of patients [43] . The authors further suggested that lower levels of DAT, resulting in higher levels of dopamine or hyperdopaminergic states and consequently sometimes in delusion and hallucination, may be related to delirium tremens [52] (see also [57, 58] ).
The abovedescribed studies were mainly carried out in male populations. Limosin et al. examined whether the 9repeat allele was also associated with withdrawal symptoms in 64 Caucasian, alcoholdependent women in a caseonly design [53] . The average number of withdrawal symptoms did not significantly differ between women with and without the 9repeat allele (p = 0.22). However, women with the 9repeat allele experienced more often at least eight (out of 11) withdrawal symptoms (p = 0.04). Further, visual hallucinations were significantly more frequent in women with the 9repeat allele when compared with women homozygous for the 10repeat allele (p = 0.03).
Other withdrawal symptoms, including alco hol withdrawal seizures and delirium tremens were not associated with the 9repeat allele.
To explain this discordance with the results of studies on male samples [46, 52, 54] , Limoson et al. stated that since male alcoholdependent sub jects suffer from more withdrawal symptoms than females, this may restrict the association between alcoholwithdrawal seizures and delir ium tremens to male alcoholics [53] . Further, they acknowledged that the small sample size (n = 64) might have resulted in decreased power to detect differences between females with the 9repeat allele and those without. Köhnke et al. compared Caucasian male and female alcoholic patients with severe withdrawal symptoms (alcoholwithdrawal seizure (AWS): n = 65; delirium tremens (DT): n = 83) to Caucasian alcoholdependent patients with only mild alcoholwithdrawal symptoms (n = 97) and did not find any differences in 9repeat allele frequencies (AWS: p = .42; for DT: p = 0.55) [50] . However, the 9repeat allele was signifi cantly more frequent in the total group of alco holics (n = 216), when compared with healthy controls (n = 102; p = .01). This association of the 9repeat allele with alcoholism was present for male alcoholics (p = 0.02), but not for their female counterparts (p = 0.18), although this latter lack of significance might be explained by the small sample size of female alcoholics (n = 40) and female controls (n = 36). Daily alcohol consumption was not significantly dif ferent for 9repeat allele carriers compared with alcoholics homozygous for the 10repeat allele. The authors concluded that the 9repeat allele was more likely to be a marker for alcoholism as such, than for severe withdrawal symptoms [50] .
Samochowiec and colleagues applied both a case-control and a familybased design in their study [47] . For the latter, the Transmission Disequilibrium Test was used. In this test it
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future science group Dopamine transporter gene (SLC6A3/DAT1) & alcohol dependence Review is examined whether an investigated allele exceeds the 50% Mendelian chance of trans mission to an alcoholdependent proband, which would imply a role in the etiology of alcohol ism. Analysis of 100 Polish families showed a significant difference in the transmission of the DAT1 VNTR 10repeat allele, which was preferentially transmitted to affected offspring (p = 0.047). Creating homogeneous subgroups of earlyonset patients and severe alcoholic patients (with seizures and/or delirium) did not result in significant differences in transmission for any of the DAT1 alleles (p = 0.34 and p = 0.66, respec tively). Subsequently, 196 control subjects were included in the study. However, no significant differences in DAT1 VNTR allele frequencies were found between the alcoholdependent participants and control subjects (pvalue not reported).
Le Strat et al. genotyped the VNTR and seven SNPs in DAT1 in a sample of 250 French alcoholdependent participants, 60 of whom had experienced withdrawal seizures [43] . When compared with 121 control subjects the 9repeat allele was not more prevelant in the entire group of alcoholdependent participants (p = 0.166). However, the 9repeat allele was significantly more frequent in alcoholdependent subjects with withdrawal seizures when compared with alcoholdependent subjects without alcohol withdrawal seizures, both in a c 2 test (p = 0.02) and in a logistic regression ana lysis (p = 0.03). In the regression ana lysis the authors controlled for confounding variables such as age of onset of alcohol dependence and alcohol dependence severity. Two other SNPs, located close to the VNTR, were also associated with withdrawal seizures. In addition, two haplotypes showed a significant protective effect for alcohol depen dence with alcoholwithdrawal seizures.
n Clinical studies of the DAT1 2319G>A SNP in alcohol dependence
The three studies described below examined another polymorphism in the 3´UTR of DAT1; 2319G>A [22] . Ueno et al. studied the prevalence of this polymorphism in a sample of Japanese subjects (n alcoholics = 124; n controls = 107) and found that the 2319A allele was significantly more frequent in alcoholic subjects than in controls (OR: 1.73; p = 0.02) [22] . The risk for alcohol ism increased with the number of 2319A alleles (p = 0.046). The 2319A allele was found only in combination with the 10, 11, and 14repeat alleles of the DAT1 VNTR, and the 2319G>A polymorphism appeared to be in significant linkage disequilibrium with the VNTR poly morphism. Haplotype analyses of the 2319G>A and VNTR polymorphism were also carried out. The haplotype of the Aallele together with the 10repeat allele of the VNTR (merged as the A10 allele) was found more often in alcohol dependent participants than in control subjects (OR: 1.76; p = 0.01), showing a significant posi tive gene dose effect (p = 0.04). In contrast, the risk for alcoholism was significantly decreased for the G10 allele (OR: 0.53; p = 0.002), with a significant negative gene dose effect (p = 0.01).
Wernicke et al. examined 351 German alco holics and 336 ethnically matched control subjects [25] . The alcoholdependent group was divided into nine subgroups: father with a positive family history of alcohol dependence; mother with a positive history of alcohol depend ence; early age at onset; delirium; withdrawal seizures; vegetative withdrawal syndrome; type 1 alcoholism; type 2 alcoholism and antisocial tendencies.
For the 2319G>A polymorphism no signifi cant difference was detected between control sub jects and alcoholic patients, neither in the total group nor in any subgroup. Two trends towards significance were found for the A/A homozygous genotype, which occurred more often in patients with withdrawal seizures (p = 0.06), and in those with an alcoholdependent mother (p = 0.08). Regarding the VNTR, the results were already published in Sander et al. ([46] discussed before). The 2319G>A polymorphism was not in signifi cant linkage disequilibrium with the VNTR, which was in contrast with the results of Ueno et al. [22] . When only individuals homozygous for the 10repeat allele of the DAT1 VNTR for genotype effects of the 2319G>A polymorphism (n patients = 183; n controls = 186) as Ueno et al. had done and no significant differences were found in 2319G>A frequency between the total group of alcoholics and controls. However, the homo zygous A10/A10 genotype was more frequently detected in patients with an alcoholic mother (OR: 5.25; p = 0.02), patients with a history of delirium (OR: 4.71; p = 0.03), and patients with a history of withdrawal seizures (OR: 7.91; p = 0.001) when compared with control subjects. The groups were also tested for differences in ethanol intake and tobacco smoking, with no significant results.
In the study by Choi et al. 111 male Korean patients with alcohol dependence were com pared with 123 male Korean control subjects on several different polymorphisms, includ ing the DAT1 2319G>A polymorphism [26] .
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The alcoholdependent subjects were divided into two groups: patients with a family history of alcohol dependence (n = 43) and patients without a family history of alcohol dependence (n = 68). Genotype and allele frequencies of the 2319G>A polymorphism were not significantly different between control subjects and subjects with a family history of alcohol dependence (p = 0.49) or subjects without a family history of alcohol dependence (p = 0.76).
Discussion
One of the first things of note from the above described studies is that a case-control design in which all alcoholdependent individuals are treated as a single group results in a very hetero geneous phenotype with a large variety of indi vidual symptoms and etiologies. As such, identify ing subgroups in which the clinical hetero geneity of alcohol dependence is taken into account may more genuinely represent reality and increases power of finding associations, if the subgroups are large enough. Excluding moderating factors (such as withdrawal symptoms) may result in the incor rect conclusion that there is no association between genotype and phenotype, while in fact there is a relationship, but only when moderating variables are taken into account (see [59] ). Munafo and Flint warn for what they call data dredging; searching for significant results in subgroups without clear a priori hypotheses [60] . Although we believe that moderating factors need to be taken into account to increase one's ability to find genetic contributors to alcohol dependence, we would also like to stress the need for adequately powered samples and clear a priori hypotheses to prevent data dredging.
Another factor that may have caused disparity in findings consists of the differences between study samples regarding psychiatric comorbid ity. Approximately one third of the reviewed studies did not, for example, give information on the exclusion or inclusion of patients with other psychiatric or substance use disorders in their study sample [23, 42, 44, 45, 47, 49, 53] . Others only reported having excluded patients with psycho sis [22, 48] or with schizophrenia or dementia [43, 52] . The DAT1 VNTR has shown to be asso ciated with ADHD (see [61] for a metaana lysis), and ADHD has in turn been related to alcohol dependence [62] . Therefore, it might be that alco holics who also have ADHD form a subgroup that is genetically more homogeneous, resulting in stronger relations with DAT1.
Other differences in the composition of samples that might have caused a lack of uni vocal results include differences in ethnicity, agerange of the sample, sex differences, match ing of cases to controls, recruitment of patients and the presence of withdrawal symptoms (see [63] ). To complicate matters further, other genes and polymorphisms, in addition to DAT1, can also be expected to contribute to the risk of developing alcoholism, since alcoholism is a polygenic disorder. Generally, if different poly morphisms are examined in relation to alcohol dependence, their effects are analyzed sepa rately, and not in interaction with each other (e.g., [47, 64] ). However, for example, Muramatsu and Higuchi revealed that the DAT1 VNTR 7repeat allele was only significantly related to alcoholism if ALDH2 genotype was also taken into account [44] . If this interaction was not included in their analyses, it would have led to the erroneous conclusion that the DAT1 VNTR was not associated with alcohol dependence in their sample. Thus, ignoring gene-gene interac tions may result in an underestimation of spe cific genetic associations to alcohol dependence [65] . We are not aware of other studies that have included interactions between DAT1 and other genes with respect to the link to alcohol depen dence, leaving ample room for future studies.
In a similar vein, environmental factors are rarely included in geneassociation studies, but have been shown to be involved in the risk for alcohol dependence. For example, social factors such as alcohol consumption of friends and fam ily [66, 67] , as well as stressful life events such as bad family relationships or childhood maltreat ment [68] [69] [70] are of considerable importance in later alcohol use and dependence. Genetic factors may pose a latent susceptibility for alcohol abuse, but environmental factors moderate whether this susceptibility comes to expression [71] . For instance, a gene-environment study of Madrid et al. demonstrated that dopamine D2 receptor (DRD2) genotype did not significantly differ between cases and controls [72] . However, when stress was included in the model, the DRD2A1 allele was significantly associated with alcohol dependence, but only in patients with highstress levels (for more examples see [73] [74] [75] ). As such, ignoring environmental factors may again lead to the wrong conclusion that certain genetic fac tors are not related to alcohol use or dependence, while in fact they are but only under specific environmental conditions [59] . The reverse is also true; environmental risk factors for alcohol use or disorders may be overlooked if they are not examined together with genetic influences.
We would like to emphasize that by high lighting gene-gene and gene-environment A u t h o r P r o o f future science group Dopamine transporter gene (SLC6A3/DAT1) & alcohol dependence Review interactions we do not aim at an uncontrolled, random search for all kinds of possible inter actions, which would probably result in many false positives. Selecting genotypes or environ mental factors based on a plausible biological mechanism or for an evidencebased reason should already decrease the chance of random gene or environment selection [76] . Genome wide association studies should be used to pro vide additional information on chromosomal areas and susceptibility genes related to alcohol dependence (e.g., [77, 78] ). In addition, multial lelic haplotypes may aid to identify the disease locus or genetic region of interest and coun ter the disadvantages of multiple testing [31] . Obviously, replication is essential to decrease the possibility of reporting false positives, as are large sample sizes.
The biological mechanisms through which the DAT1 VNTR or 2139G>A polymorphisms influence alcoholrelated behaviors are still largely unclear. As such, it is perhaps a step too far to already jump to associating a poly morphism with a clinical phenotype. Research that focuses on the biological or neuro biological mechanisms that underlie the supposed link between gene and phenotype are highly war ranted. In addition, a way to reduce the distance between gene and phenotype is to concentrate on endophenotypes that mediate this associa tion (e.g., [79] ). Endophenotypes can consist of biological, neurological, or cognitive variables, such as craving, levels of intoxication or euphoria postalcohol consumption, alcohol metabolism, brain waves, or expectations of alcohol consump tion (for a review see [80] ).
A final shortcoming of the reviewed studies is that most studies are fairly small and may lack power to accurately examine the role of DAT1 in alcoholism, hereby increasing the risk for false negatives. In addition, the DAT1 3´UTR VNTR is a polymorphism with several differ ent alleles, which further reduces the power of association studies. To tackle power problems and to carry out reliable replication studies very large sample sizes are needed [81] . To show that sample sizes need to be extremely large under certain circumstances, we took one reviewed study [46] as a representative for power and sam ple size calculations (Table 3) . Systematic reviews and metaanalyses could be used to synthesize data from separate studies and counter the need for extremely large individual sample sizes [76] .
The specification of subgroups of alcohol dependent persons for which a certain polymor phism is a risk factor is only beginning to emerge, but may have great implications for the treat ment of alcoholism. Further, specific subgroups may have a more homogeneous genetic cause of disease, which in turn may provide additional information on specific biological mechanisms. Although large sample sizes are needed to take so many variables into account, this would allow researchers to adopt a more individual, personal ized approach, which may be very well translat able to clinical practice (see [82] ).
n Future perspective Even though this description of potential dif ficulties in geneassociation studies is not meant to be exhaustive (see also [59, 63, 83] ), it is clear that challenges for future gene association studies are [82] . 
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Executive summary
Generally, clinical studies showed inconsistent support for a relationship between polymorphisms in the DAT1 gene and alcohol dependence. Several, but not all, studies found that the DAT1 VNTR (9-repeat allele) was associated with alcohol-withdrawal symptoms, such as seizures and delirium tremens.
Shortcomings of current studies on DAT1 and alcohol dependence include:
Small sample sizes, lack of power. Disregarding the polygenic nature of the disorder and gene-gene interactions. 80, 191-198 (2008) .
